Start-up
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV
Learn MoreOngoing
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
Learn MoreEnrolling
Enrolling
Longitudinal impacts of violence and stigma on HIV care continuum and broader health care access among women living with HIV
Learn MoreEnrolling
The role of female sex hormones and chronic/latent co-infections on cellular aging and comorbidities in women living with HIV
Learn MoreOngoing
Preventing HIV by targeting the immune system instead of the virus
Learn MoreReporting
Improving vaginal health to decrease biological risk of HIV-1 infection in Canadian ACB women
Learn MoreOngoing
Indigenous, participatory evaluation and assessment of a culturally-grounded and arts-informed intervention for HIV-positive Aboriginal women
Learn MoreCompleted
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
